{"id":4312,"date":"2021-12-02T02:46:54","date_gmt":"2021-12-02T02:46:54","guid":{"rendered":"\/\/smallcapscn.x5view.co\/?p=4312"},"modified":"2023-08-29T17:52:12","modified_gmt":"2023-08-29T17:52:12","slug":"amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886","status":"publish","type":"post","link":"https:\/\/smallcapscn.x5view.co\/?p=4312","title":{"rendered":"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886"},"content":{"rendered":"<p>\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002<\/p>\n<p>\u8be5\u516c\u53f8\u6839\u636e\u7ef4\u591a\u5229\u4e9a\u5dde\u653f\u5e9c\u7684\u7814\u7a76\u53ca\u53d1\u5c55\u73b0\u91d1\u6d41\u52a8\u8d37\u6b3e\u8ba1\u5212\uff0c\u7533\u8bf7\u4e8c\u767e\u4e00\u5341\u4e07\u6fb3\u5143\u7684\u8bbe\u65bd\u3002<\/p>\n<p><iframe loading=\"lazy\" title=\"Amplia Therapeutics makes headway in anti-cancer clinical trial\" src=\"https:\/\/www.youtube.com\/embed\/IlGTC2HFbPg?feature=oembed\" width=\"452\" height=\"254\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><br \/>\n\u8fd9\u7b14\u8d44\u91d1\u5c06\u5206\u4e24\u90e8\u5206\u53d1\u653e\u7ed9Amplia\uff0c\u9996\u6279130\u4e07\u6fb3\u5143\u9884\u8ba1\u5c06\u4e8e\u672c\u6708\u53d1\u653e\uff0c\u5176\u4f5980\u4e07\u6fb3\u5143\u5c06\u4e8e\u660e\u5e743\u6708\u5e95\u524d\u53d1\u653e\u3002<\/p>\n<p>Amplia\u5c06\u5229\u7528\u8fd9\u7b14\u8d44\u91d1\u5feb\u901f\u5f00\u53d1AMP886\uff0c\u5305\u62ec\u8bc4\u4f30\u8be5\u836f\u7269\u7684\u65b0\u6cbb\u7597\u673a\u4f1a\u548c\u542f\u52a8\u4e34\u5e8a\u524d\u6d3b\u52a8\uff0c\u4ee5\u652f\u6301\u672a\u6765\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n<p>Amplia\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406John Lambert\u535a\u58eb\u8868\u793a:\u201c\u8fd9\u7b14\u8d37\u6b3e\u4f7f\u6211\u4eec\u80fd\u591f\u6bd4\u539f\u8ba1\u5212\u66f4\u65e9\u3001\u66f4\u79ef\u6781\u5730\u542f\u52a8\u7b2c\u4e8c\u4e2a\u8d44\u4ea7AMP886\u7684\u5de5\u4f5c\u3002\u201d<\/p>\n<h2>FAK\u6291\u5236\u5242<\/h2>\n<p>\u8be5\u516c\u53f8\u8868\u793a\uff0cFAK\u662f\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u7684\u4e00\u4e2a\u201c\u8d8a\u6765\u8d8a\u91cd\u8981\u7684\u9776\u70b9\u201d\u3002<\/p>\n<p>FAK\u4e0e\u8bb8\u591a\u764c\u75c7\u9632\u5fa1\u673a\u5236\u6709\u5173\uff0c\u8fd9\u4e9b\u673a\u5236\u4f1a\u964d\u4f4e\u6297\u764c\u836f\u7269\u7684\u6709\u6548\u6027\u3002<\/p>\n<p>\u764c\u75c7\u4e2dFAK\u6c34\u5e73\u5347\u9ad8\u901a\u5e38\u4e0e\u4e0d\u826f\u9884\u540e\u76f8\u5173\u3002<\/p>\n<p>Amplia\u6b63\u5728\u5f00\u53d1FAK\u6291\u5236\u5242\uff0c\u4ee5\u7834\u574f\u764c\u75c7\u9632\u5fa1\u673a\u5236\uff0c\u4f7f\u5176\u5bf9\u5316\u7597\u548c\u5176\u4ed6\u836f\u7269\u6cbb\u7597\u66f4\u654f\u611f\u3002<\/p>\n<p>AMP886\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u9636\u6bb5\uff0c\u8be5\u516c\u53f8\u6b63\u5728\u5f00\u53d1\u5b83\u4f5c\u4e3a\u552f\u4e00\u7684\u6cbb\u7597\u65b9\u6cd5\u3002<\/p>\n<h2>\u5148\u8fdb\u7684\u94c5\u836f\u7269AMP945<\/h2>\n<p>Facility funds\u4e5f\u5c06\u7528\u4e8e\u6269\u5927Amplia\u7684\u9886\u5148FAK\u6291\u5236\u5242AMP945\u7684\u6297\u7ea4\u7ef4\u5316\u6f5c\u529b\u7684\u7814\u7a76\u8303\u56f4\u3002<\/p>\n<p>\u8fd9\u79cd\u836f\u7269\u76ee\u524d\u6b63\u88ab\u5f00\u53d1\u7528\u4e8e\u534f\u52a9\u6cbb\u7597\u80f0\u817a\u764c\u3002<\/p>\n<p>Lambert\u535a\u58eb\u8bf4\uff0cAMP945\u7684\u4e8c\u671f\u4e34\u5e8a\u7814\u7a76\u5df2\u7ecf\u5f97\u5230\u8d44\u52a9\uff0c\u5c06\u4e8e\u660e\u5e74\u5e74\u521d\u5f00\u59cb\u3002<\/p>\n<p>\u8fd9\u9879\u7814\u7a76\u5c06\u8bc4\u4f30\u5728\u5409\u897f\u4ed6\u6ee8\u548cAbraxane\u8054\u5408\u5316\u7597\u4e2d\u52a0\u5165AMP945\uff0c\u540e\u8005\u662f\u76ee\u524d\u7528\u4e8e\u65b0\u8bca\u65ad\u80f0\u817a\u764c\u60a3\u8005\u7684\u62a4\u7406\u6807\u51c6\u3002<\/p>\n<p>\u4e3a\u4e86\u534f\u52a9\u7814\u7a76\uff0c<a href=\"http:\/\/smallcaps-production.test\/amplia-therapeutics-secures-renowned-oncology-drug-development-expert-clinical-advisor\/?lang=cn\">Amplia\u572810\u6708\u83b7\u5f97\u4e86\u8457\u540d\u7684\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Jos\u00e9 Iglesias\u535a\u58eb\u4f5c\u4e3a\u4e34\u5e8a\u987e\u95ee\u3002<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002 \u8be5\u516c\u53f8\u6839\u636e\u7ef4\u591a\u5229\u4e9a\u5dde\u653f\u5e9c\u7684\u7814\u7a76\u53ca\u53d1\u5c55\u73b0\u91d1\u6d41\u52a8\u8d37\u6b3e\u8ba1\u5212\uff0c\u7533\u8bf7\u4e8c\u767e\u4e00\u5341\u4e07\u6fb3\u5143\u7684\u8bbe\u65bd\u3002 \u8fd9\u7b14\u8d44\u91d1\u5c06\u5206\u4e24\u90e8\u5206\u53d1\u653e\u7ed9Amplia\uff0c\u9996\u6279130\u4e07\u6fb3\u5143\u9884\u8ba1\u5c06\u4e8e\u672c\u6708\u53d1\u653e\uff0c\u5176\u4f5980\u4e07\u6fb3\u5143\u5c06\u4e8e\u660e\u5e743\u6708\u5e95\u524d\u53d1\u653e\u3002 Amplia\u5c06\u5229\u7528\u8fd9\u7b14\u8d44\u91d1\u5feb\u901f\u5f00\u53d1AMP886\uff0c\u5305\u62ec\u8bc4\u4f30\u8be5\u836f\u7269\u7684\u65b0\u6cbb\u7597\u673a\u4f1a\u548c\u542f\u52a8\u4e34\u5e8a\u524d\u6d3b\u52a8\uff0c\u4ee5\u652f\u6301\u672a\u6765\u7684\u4e34\u5e8a\u8bd5\u9a8c\u3002 Amplia\u9996\u5e2d\u6267\u884c\u5b98\u517c\u8463\u4e8b\u603b\u7ecf\u7406John Lambert\u535a\u58eb\u8868\u793a:\u201c\u8fd9\u7b14\u8d37\u6b3e\u4f7f\u6211\u4eec\u80fd\u591f\u6bd4\u539f\u8ba1\u5212\u66f4\u65e9\u3001\u66f4\u79ef\u6781\u5730\u542f\u52a8\u7b2c\u4e8c\u4e2a\u8d44\u4ea7AMP886\u7684\u5de5\u4f5c\u3002\u201d FAK\u6291\u5236\u5242 \u8be5\u516c\u53f8\u8868\u793a\uff0cFAK\u662f\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u7684\u4e00\u4e2a\u201c\u8d8a\u6765\u8d8a\u91cd\u8981\u7684\u9776\u70b9\u201d\u3002 FAK\u4e0e\u8bb8\u591a\u764c\u75c7\u9632\u5fa1\u673a\u5236\u6709\u5173\uff0c\u8fd9\u4e9b\u673a\u5236\u4f1a\u964d\u4f4e\u6297\u764c\u836f\u7269\u7684\u6709\u6548\u6027\u3002 \u764c\u75c7\u4e2dFAK\u6c34\u5e73\u5347\u9ad8\u901a\u5e38\u4e0e\u4e0d\u826f\u9884\u540e\u76f8\u5173\u3002 Amplia\u6b63\u5728\u5f00\u53d1FAK\u6291\u5236\u5242\uff0c\u4ee5\u7834\u574f\u764c\u75c7\u9632\u5fa1\u673a\u5236\uff0c\u4f7f\u5176\u5bf9\u5316\u7597\u548c\u5176\u4ed6\u836f\u7269\u6cbb\u7597\u66f4\u654f\u611f\u3002 AMP886\u76ee\u524d\u5904\u4e8e\u4e34\u5e8a\u524d\u9636\u6bb5\uff0c\u8be5\u516c\u53f8\u6b63\u5728\u5f00\u53d1\u5b83\u4f5c\u4e3a\u552f\u4e00\u7684\u6cbb\u7597\u65b9\u6cd5\u3002 \u5148\u8fdb\u7684\u94c5\u836f\u7269AMP945 Facility funds\u4e5f\u5c06\u7528\u4e8e\u6269\u5927Amplia\u7684\u9886\u5148FAK\u6291\u5236\u5242AMP945\u7684\u6297\u7ea4\u7ef4\u5316\u6f5c\u529b\u7684\u7814\u7a76\u8303\u56f4\u3002 \u8fd9\u79cd\u836f\u7269\u76ee\u524d\u6b63\u88ab\u5f00\u53d1\u7528\u4e8e\u534f\u52a9\u6cbb\u7597\u80f0\u817a\u764c\u3002 Lambert\u535a\u58eb\u8bf4\uff0cAMP945\u7684\u4e8c\u671f\u4e34\u5e8a\u7814\u7a76\u5df2\u7ecf\u5f97\u5230\u8d44\u52a9\uff0c\u5c06\u4e8e\u660e\u5e74\u5e74\u521d\u5f00\u59cb\u3002 \u8fd9\u9879\u7814\u7a76\u5c06\u8bc4\u4f30\u5728\u5409\u897f\u4ed6\u6ee8\u548cAbraxane\u8054\u5408\u5316\u7597\u4e2d\u52a0\u5165AMP945\uff0c\u540e\u8005\u662f\u76ee\u524d\u7528\u4e8e\u65b0\u8bca\u65ad\u80f0\u817a\u764c\u60a3\u8005\u7684\u62a4\u7406\u6807\u51c6\u3002 \u4e3a\u4e86\u534f\u52a9\u7814\u7a76\uff0cAmplia\u572810\u6708\u83b7\u5f97\u4e86\u8457\u540d\u7684\u80bf\u7624\u836f\u7269\u5f00\u53d1\u4e13\u5bb6Jos\u00e9 Iglesias\u535a\u58eb\u4f5c\u4e3a\u4e34\u5e8a\u987e\u95ee\u3002<\/p>\n","protected":false},"author":3,"featured_media":14116,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[3],"tags":[58],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v17.3 (Yoast SEO v21.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886<\/title>\n<meta name=\"description\" content=\"\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886\" \/>\n<meta property=\"og:description\" content=\"\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002\" \/>\n<meta property=\"og:url\" content=\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/\" \/>\n<meta property=\"og:site_name\" content=\"smallcapsCN\" \/>\n<meta property=\"article:published_time\" content=\"2021-12-02T02:46:54+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-29T17:52:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Amplia-Therapeutics-ASX-ATX-RD-cash-flow-loan-funding-Victorian-Government.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"640\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lorna Nicholas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lorna Nicholas\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/\",\"url\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/\",\"name\":\"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886\",\"isPartOf\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\"},\"datePublished\":\"2021-12-02T02:46:54+00:00\",\"dateModified\":\"2023-08-29T17:52:12+00:00\",\"author\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\"},\"description\":\"\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002\",\"breadcrumb\":{\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/smallcapscn.x5view.co\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#website\",\"url\":\"https:\/\/smallcapscn.x5view.co\/\",\"name\":\"smallcapsCN\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60\",\"name\":\"Lorna Nicholas\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g\",\"caption\":\"Lorna Nicholas\"},\"description\":\"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.\",\"url\":\"https:\/\/smallcapscn.x5view.co\/?author=3\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886","description":"\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886","og_description":"\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002","og_url":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/","og_site_name":"smallcapsCN","article_published_time":"2021-12-02T02:46:54+00:00","article_modified_time":"2023-08-29T17:52:12+00:00","og_image":[{"width":640,"height":400,"url":"https:\/\/smallcapscn.x5view.co\/wp-content\/uploads\/2023\/08\/Amplia-Therapeutics-ASX-ATX-RD-cash-flow-loan-funding-Victorian-Government.jpg","type":"image\/jpeg"}],"author":"Lorna Nicholas","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Lorna Nicholas"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/","url":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/","name":"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886","isPartOf":{"@id":"https:\/\/smallcapscn.x5view.co\/#website"},"datePublished":"2021-12-02T02:46:54+00:00","dateModified":"2023-08-29T17:52:12+00:00","author":{"@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60"},"description":"\u5236\u836f\u516c\u53f8Amplia Therapeutics (ASX: ATX)\u83b7\u5f97\u4e86210\u4e07\u6fb3\u5143\u7684\u653f\u5e9c\u8d44\u52a9\uff0c\u4ee5\u52a0\u5feb\u5176\u7b2c\u4e8c\u79cd\u5c40\u7076\u7c98\u9644\u6fc0\u9176(FAK)\u6291\u5236\u5242AMP886\u7684\u5de5\u4f5c\uff0c\u7528\u4e8e\u6cbb\u7597\u764c\u75c7\u548c\u7ea4\u7ef4\u5316\u75be\u75c5\u3002","breadcrumb":{"@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/smallcapscn.x5view.co\/amplia-therapeutics-receives-grant-fast-track-second-cancer-drug-amp886\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/smallcapscn.x5view.co\/"},{"@type":"ListItem","position":2,"name":"Amplia Therapeutics\u83b7\u5f97210\u4e07\u6fb3\u5143\u7684\u62e8\u6b3e\uff0c\u7528\u4e8e\u5feb\u901f\u5f00\u53d1\u7b2c\u4e8c\u79cd\u6297\u764c\u836f\u7269AMP886"}]},{"@type":"WebSite","@id":"https:\/\/smallcapscn.x5view.co\/#website","url":"https:\/\/smallcapscn.x5view.co\/","name":"smallcapsCN","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/smallcapscn.x5view.co\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/3e816860d3443582b1918467347eeb60","name":"Lorna Nicholas","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/smallcapscn.x5view.co\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/431dd83ad861252293034fed39d5d7a5?s=96&d=mm&r=g","caption":"Lorna Nicholas"},"description":"Lorna has more than 15 years' experience as a business\/finance journalist and editor. She has written for numerous industry publications reporting on various sectors, including: resources, energy, construction, biotech, pharma, science and technology, agriculture, and chemicals. Specialising in resources, Lorna has also covered a myriad of small and large cap ASX and dual-listed stocks.","url":"https:\/\/smallcapscn.x5view.co\/?author=3"}]}},"_links":{"self":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4312"}],"collection":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4312"}],"version-history":[{"count":1,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4312\/revisions"}],"predecessor-version":[{"id":14115,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/posts\/4312\/revisions\/14115"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=\/wp\/v2\/media\/14116"}],"wp:attachment":[{"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4312"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4312"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smallcapscn.x5view.co\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4312"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}